Skip to main content

Day: March 30, 2025

First Three Children to Commence Treatment With Ryoncil®

United States Centers for Medicare and Medicaid Services (CMS) Mandates Ryoncil® Coverage NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) — Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has entered into the Medicaid National Drug Rebate Agreement (NDRA) with the U.S. Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services, for Ryoncil® (remestemcel-L), the first mesenchymal stromal cell (MSC) therapy approved by U.S. Food and Drug Administration (FDA) for any indication. The NDRA agreement with Mesoblast means that the U.S. Government now provides inpatient and outpatient access for a treatment course of Ryoncil® to the approximately 40% of U.S. children covered by Medicaid who have steroid-refractory acute graft...

Continue reading

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study

SAN CARLOS, Calif., March 30, 2025 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced it will hold a webcast and conference call tomorrow, March 31, 2025, at 8:00 a.m. Eastern Time to present topline results from the VAX-24 infant Phase 2 study. This study is evaluating the safety, tolerability and immunogenicity of VAX-24, the Company’s 24-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease (IPD), compared to Prevnar 20® in healthy infants. To participate in the conference call, please dial 800-445-7795 (domestic) or 785-424-1699 (international) and refer to conference ID PCVX0331. A live webcast of the conference call...

Continue reading

FirstFarms A/S: Confirmed case of Foot and Mouth Disease on farm in Slovakia

The Slovak authorities have confirmed an outbreak of Foot and Mouth Disease (FMD) on 30 March 2025 in a livestock of 3,487 animals on FirstFarms’ farm in Plavecký Stvrtok, Slovakia. The Slovak authorities have activated their outbreak contingency plan, which includes, among other things, the closure and isolation of the farm and the establishment of restriction zones. This is done to limit the risk of infection spreading.FirstFarms is working closely with the authorities to prevent the spread of infection and vaccination of the animals is in progress. The outbreak on FirstFarms’ farm in Slovakia is the first in the company’s history but the fifth in Slovakia this year. Since the first outbreak was recorded on 22 March 2025, FirstFarms has been on alert at all of its farms in Slovakia, and all safety regulations have been implemented and...

Continue reading

Possible symptoms of Foot and Mouth Disease in one animal in FirstFarms’ herd in Slovakia

On 30 March 2025, FirstFarms has seen possible symptoms of Foot and Mouth Disease (FMD) in one animal in a livestock of 3,487 animals on FirstFarms’ farm in Plavecky Stvrtok, Slovakia. The local authorities have been contacted, and the state veterinarian has carried out tests on the cow, the results of which are not yet available. FirstFarms has for now no further comments. FirstFarms will provide further information when the results are available. Foot and mouth disease is one of the most serious infectious diseases of livestock. All cloven-hooved animals, including cattle, pigs, wild ruminants, sheep and goats, are susceptible to the disease, which cannot be cured. Foot and mouth disease cannot be transmitted to humans, but humans can transmit the infection to animals, both through direct and indirect contact with animals. Best regards,FirstFarms...

Continue reading

BYD Energy Storage Launches Chess Plus for C&I Energy Storage in China

BEIJING, March 30, 2025 (GLOBE NEWSWIRE) — BYD Energy Storage, a business division of BYD Company Limited, as a provider of renewable energy solutions, unveiled on March 26th its next-gen commercial and industrial (C&I) energy storage system, Chess Plus, designed to address challenges in safety, efficiency, and profitability amid a fiercely competitive market.BYD Energy Storage’s Chess Plus establishes a new paradigm in energy storage through its cell-to-system (CTS) protection framework. At the core are “Thick Blade Battery” cells with ceramic terminals, eliminating leakage risks while enhancing corrosion resistance. These cells have passed extreme stress tests including thermal runaway simulations (-25~55℃) and 260% overcharge thresholds. Chess Plus is unique with its 2-hour fire-resistant battery casing and built-in aerosol...

Continue reading

Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress

CUPERTINO, Calif., March 30, 2025 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, announced today topline data from the long-term open label extension portion of the Phase 3 RECOVER study evaluating brilaroxazine in schizophrenia will be presented as part of an oral presentation at the 2025 Congress of the Schizophrenia International Research Society (SIRS) taking place March 29 to April 2, 2025 in Chicago, Illinois, U.S. Details for the oral presentation can be found below: Title: Brilaroxazine Phase 3 Recover 52-Week Open-Label Evaluation of Efficacy and Safety over 12 Months in Stable Schizophrenia Participants Session: Pharmaceutical...

Continue reading

EHang’s EH216-S eVTOL Operators Obtain Air Operator Certificates

GUANGZHOU, China, March 30, 2025 (GLOBE NEWSWIRE) — EHang (Nasdaq: EH), the world’s leading Urban Air Mobility (UAM) technology platform company, announced that its wholly-owned subsidiary, Guangdong EHang General Aviation Co., Ltd. (“EHang General Aviation”), and its joint venture company in Hefei, Hefei HeYi Aviation Co., Ltd. (“HeYi Aviation”), have been granted the first batch of Air Operator Certificates (“OC”) for civil human-carrying pilotless aerial vehicles by the Civil Aviation Administration of China (“CAAC”). This milestone officially marks the launch of China’s human-carrying flight era in the low-altitude economy, allowing citizens and consumers to purchase flight tickets for low-altitude tourism, urban sightseeing, and diverse commercial human-carrying flight services at related operation sites in Guangzhou and Hefei....

Continue reading

Kaldalón hf.: Annual General Meeting – Final Agenda and Board Candidates

Kaldalón hf. hereby announces that its Annual General Meeting will be held on Thursday, April 3, 2025, at 16:00. The meeting will take place at Reykjavík Natura, Nauthólsvegur 52, 101 Reykjavík.Please note that the meeting will be conducted in Icelandic. The deadline to submit candidacies for the Board of Directors has passed. The following individuals have declared their candidacy for the Board of Directors of Kaldalón hf.:Álfheiður Ágústsdóttir Ásgeir Helgi Reykfjörð Gylfason Haukur Guðmundsson Haukur Hafsteinsson Pálína María GunnlaugsdóttirThe following individuals have declared their candidacy as alternate members of the Board:Gunnar Henrik B. Gunnarsson Hildur LeifsdóttirFurther information about the candidates is available in the Nomination Committee’s report, published on March 11. The report, along with the...

Continue reading

KOIL Energy Announces Delay in Filing of Annual Report on Form 10-K and anticipates reporting profitable growth in revenues

HOUSTON, March 29, 2025 (GLOBE NEWSWIRE) — Koil Energy Solutions, Inc. (OTCQB: KLNG), (the “Company”) today announced that it will be filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, with the Securities and Exchange Commission (the “SEC”) later than the originally scheduled date of March 31, 2025. The Company anticipates filing the Annual Report within the extended timeframe granted by the SEC of fifteen days. The delay is due to the requirement to complete certain audit procedures after a material weakness in internal control over financial reporting was discovered during the final review cycle. The Company’s financial statements are being updated to reflect a $140,000 accrual for expired stock options that had been reversed in a manner inconsistent with Accounting Standards Codification 718....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.